Zydus Aeroforce

Aeroforce logo-cdr

Aeroforce is committed towards respiratory care, it was incepted in April 2011. The division focuses on transforming the treatment of Chronic Obstructive Pulmonary Disease (COPD), Asthma along with Allergic Rhinitis, and Interstitial Lung Disease by driving early, biology-led treatments.

In 2016, Aeroforce introduced World’s First Formoterol and Glycopyrronium DPI –”Forglyn” – Breakthrough in COPD. Later it launched “Forglyn pMDI” as India’s first pressurized Metered Dose Inhaler (pMDI) to expand the possibilities in COPD care. Aeroforce has an impressive product portfolio that includes Aerohale Spacer, Forair, Nindev, Formosone, and other solutions to help manage the respiratory disorder.

Our Leading Brands

Divisional Achievements

The Forglyn brand is recognized as the No. 1 brand in Glycopyrronium and Formoterol category. (Source: AIOCD AWACS JAN’ 21)

See All Division of Zydus Healthcare Limited